Biotech Co. Neurona Therapeutics Raises $120M
By Yeji Jesse Lee · February 8, 2024, 9:12 PM EST
Clinical stage biotech company Neurona Therapeutics announced Thursday that it raised $120 million to advance the development of its lead treatment NRTX-1001 as well as other preclinical programs....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login